Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.
about
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewImproving mental health service users' with medical co-morbidity transition between tertiary medical hospital and primary care services: a qualitative studyMay the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry.Neurology issues in schizophrenia.Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.The microbiome, immunity, and schizophrenia and bipolar disorderPrevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs.Strategies to improve medication adherence in patients with schizophrenia: the role of support services.Metagenomic Sequencing Indicates That the Oropharyngeal Phageome of Individuals With Schizophrenia Differs From That of Controls.Frequency of anemia in chronic psychiatry patients.Probable clozapine-induced parenchymal lung disease and perimyocarditis: a case reportMental health consumers' with medical co-morbidity experience of the transition through tertiary medical services to primary care.The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis.Is it time for immunopsychiatry in psychotic disorders?Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.The use of deceased controls in epidemiological research: A systematic review.Improving care planning and coordination for service users with medical co-morbidity transitioning between tertiary medical and primary care services.Socio-environmental factors associated with diabetes mellitus among patients hospitalized with schizophrenia in Japan.Risk factors for mortality in Down syndrome.Potential role of amino acids in pathogenesis of schizophrenia.Anxiety disorders and physical comorbidity: increased prevalence but reduced relevance of specific risk factors for hospital-based mortality during a 12.5-year observation period in general hospital admissions.Lack of tolerable treatment options for patients with schizophrenia.Comorbidity, stigma and emotional perception in psychiatric disorders.What are the top 10 physical activity research questions in schizophrenia?Safety of service users with severe mental illness receiving inpatient care on medical and surgical wards: A systematic review.Assessment of biological, psychological and adherence factors in the prediction of step-down treatment for patients with well-controlled asthma.Cardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia.Cognitive Remediation in Middle-Aged or Older Inpatients with Chronic Schizophrenia: A Randomized Controlled Trial in Korea.Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD
P2860
Q28248117-A9EC8FA3-CCA2-4D40-A3FA-08E7C53BB824Q30390958-8B550EEF-1C1C-4425-8711-6350A8D3FA14Q30489570-7D31D291-68A2-4F3A-88AB-9AC2DBDA0142Q30910367-00EAD678-528E-4687-AAF1-B1B8E89FD528Q33670588-EEF195CF-3E10-472D-AD66-961A2C6B2D47Q33887751-84A82DE4-C003-4050-B501-89CE14543DAAQ34029493-3CA71358-F1E6-4124-AF5E-2A8ED6698863Q35507000-4B78D49F-23B3-46B7-9AB0-75BF07F00BA9Q35558549-D8B08210-E628-4061-B98F-C565DA378AA5Q36212937-F3F20317-E1D9-4033-A028-8215A294F516Q36216518-1BE61E96-EFA4-419E-A869-A44987915C94Q36807212-419CC232-A123-47EB-8BA8-47E77CB17A33Q38460789-A861F4F7-9E79-425C-A8E5-68A47D74B876Q38779149-B0559E5C-94E6-4895-B08E-05D71FE91AE6Q39024232-CBDF0B67-17C4-421D-8729-874B99911F18Q39275474-D7707EC5-AADD-454C-9335-89740E70CAF6Q39513465-D7236B80-0A22-4810-BBC4-5A172C19A930Q39570101-206314DE-33C8-4741-BF63-56B7A6DB5C64Q41103904-A2FEABCD-1E28-46FA-8944-C0EB0FC56B2BQ41706313-35B18422-84A5-4655-9817-EF6F3C50735CQ41729610-1C17D0B4-A314-4CDC-9B74-4BCA337F8ABDQ42120078-6F3DE9E2-02EF-40F6-8537-4E41258F9540Q43681461-ECAC1A7D-EAE2-4A0C-90BD-1FF2BB0AAD08Q46179486-D4D7091C-A60A-403E-AB3A-32EAC55346BAQ47557401-C9980C35-7049-4AE5-BD72-55E1348C0741Q47772446-CC30590E-5275-46AA-9DD2-3514EDF837AAQ49583891-52739EC2-37EF-4141-93F0-21268C838681Q50535379-9A58A730-5FDF-45B8-B724-CB8EE3CE96B3Q57777307-7A912A34-A4EB-4EDF-AD2C-4EBD6983A14E
P2860
Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Physical comorbidity and its r ...... n general hospital admissions.
@en
Physical comorbidity and its r ...... n general hospital admissions.
@nl
type
label
Physical comorbidity and its r ...... n general hospital admissions.
@en
Physical comorbidity and its r ...... n general hospital admissions.
@nl
prefLabel
Physical comorbidity and its r ...... n general hospital admissions.
@en
Physical comorbidity and its r ...... n general hospital admissions.
@nl
P2093
P2860
P1476
Physical comorbidity and its r ...... in general hospital admissions
@en
P2093
Hardeep Uppal
Rahul Potluri
Reinhard Heun
P2860
P2888
P356
10.1007/S00406-013-0436-X
P577
2013-08-13T00:00:00Z